Skip to content

The efficacy of acupuncture in spasm after stroke

Comparison of the effect of acupuncture versus sham acupuncture in reducing the incidence rate of spasm and alleviate the severity of spasm in adult patients: a multicentre randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84985339
Enrollment
254
Registered
2010-10-19
Start date
2009-08-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

A total of 254 patients in the acute stage of Cerebral apoplexy will be recruited. One half of the patients are from the Acupuncture Department of Beijing Huguosi Chinese Medicine Hospital while the o
ICP (Intracranial Pressure) control, blood pressure control, platelet aggregation, trophic nerve, routine physiotherapy and occupational therapy for 4 weeks. 2. The control group: the sham acupunctur

Sponsors

Beijing Municipal Science and Technology Commission (China)
Lead Sponsor
Beijing Hospital of Traditional Chinese Medicine (China)
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Stroke patients were diagnosed according to criteria of cerebral arterial thrombosis in Western medicine and the criteria of apoplexy in Chinese medicine 2. Stroke occurred within 14 days 3. Male or female, aged 40-75 4. National Institute of Health Stroke Scale (NIHSS) grade from 4 to 21 5. The muscle strength of the affected limbs is less than grade 3 6. No disorder of consciousness according to Glasgow Coma Scale (GCS) 7. Patients suffering their first attack or with a cerebral stroke history but with on serious deformity, modified Rankin SCale (mRS) grade >1 8. Diagnosed by the computed tomography (CT) or magnetic resonance imaging (MRI) 9. Patients who took part in the trial voluntarily and signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. Patients receiving treatment for thrombolysis 2. Patients also have other neurological diseases or other illness which may cause abnormal muscle tension 3. Patients involved in other clinical trials, or having undergone other clinical trials in the last 3 months 4. Patients with severe primary diseases of the cardiovascular system, liver, kidney, hematopoietic system, or psychopathy 5. Pregnant women or women who are breastfeeding 6. Congenital disabilities

Design outcomes

Primary

MeasureTime frame
1. Modified Ashworth Scale for Spasticity (MASS) 2. Fugl-Meyer (FMA) 3. Motor assessment scale (MAS) Assessments will be conducted at baseline and at week 2, 4 and 12 follow-up.

Secondary

MeasureTime frame
1. Activities of daily living (ADL) 2. The NIH Stroke Scale (NIHSS) 3. Stroke Speciality-Quality of Life (SS-QOL) 4. Modified Rankin Scale (mRS) Assessments will be conducted at baseline and at week 2, 4 and 12 follow-up, it is likely to adopt the follow up face to face.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026